Raymond James analyst Gary Nachman initiated coverage of Jazz Pharmaceuticals with a Market Perform rating and no price target.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on JAZZ: